Egis

Email address and contacts

Egis company description

About us We are one of the leading generic pharmaceutical companies in Central Eastern Europe, and our activities incorporate all areas of the pharmaceutical value chain. Egis is a member of the Servier Group, an international pharmaceutical company governed by a non-profit foundation with its headquarters in France. In the 2017/2018 financial year Egis Group generated net sales of EUR 498 million. Besides Hungary, we sell our products under Egis’ brand names in 17 countries through our network of subsidiaries and representative offices. Our products range from active ingredients, through tablets and injections, to galenic (i.e. liquid and semi-solid) formulations and are available in 71 countries through our network of subsidiaries and representative offices or partners. Our main focus lies on treating diseases of the cardiovascular and central nervous systems; however, we also provide modern treatment solutions in the fields of oncology and women’s health. In 2013, we launched our first biosimilar monoclonal antibody product. This was also the first biosimilar monoclonal antibody (mAb) in the European Union. Since then we launched three additional biosimilar drugs. As one of the companies in the Central Eastern European region firmly committed to innovation, we devote approximately EUR 50 million yearly to R&D. Our research and development activities focus on high-quality, value-added branded generic products. In the last twenty years we have invested more than EUR 690 million in improvements — such as modernizing the complete process of our finished product manufacturing, as well as establishing state-of-the-art R&D centers in Hungary. Development of highly potent (meaning having significant biological activity in very small doses) drug substances and finished products has also become possible at our site in Budapest. In the 2017/2018 financial year, the comprehensive modernization of the traditional technology of active ingredient manufacturing was completed.

Key Employees

?
************
Regulatory Affairs Manager
Find Email
A
Anna Grecsina
Regulatory Affairs Manager
A
Anzhela Stohnii
regulatory affairs manager
N
Narcisz Ficzere-Kocsis
Regulatory Affairs Manager
H
Henrietta Tóth-Fekete
Regulatory Affairs Manager
S
Szilvácsku Dóra
Regulatory Affairs Manager
I
Ivett Péter
Regulatory Affairs Manager
Sign up to open these and 5 more emails in Egis
Message error line

Egis competitors and alternatives

Lash Group
Pharmaceuticals
1826 employees
Genoa Healthcare
Pharmaceuticals
1729 employees
Bracco
Pharmaceuticals
1684 employees
Hovione
Pharmaceuticals
1552 employees
Vetoquinol Global
Pharmaceuticals
1471 employees
Acino
Pharmaceuticals
1452 employees
View all competitors

Recently updated team members of Egis

R
Renáta Gilincsek
K
Krisztina Dekan
Senior GMP Engineer
T
Tymur Polischuk
Commercial Manager
S
Szabolcs Nagy
Head, IT Project Management Office
R
Reka Szalaga
Human Resources Manager
Z
Zsuzsa Rindt
Human Resources Project Manager
View all employees

GetProspect Email Finder

Retrieve thousands of email addresses in single click without leaving your current tab. Download for free now!

100 Free emails every month

Add to Chrome

400+ reviews 50,000+ users

Ready to get started?

Try GetProspect email finder for free, and explore all the tools you need to scale your business

Real data
No credit card needed
Leave any time
Find Emails